Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CSL Ltd (OTC Pink - Current Information:CSLLY)

37.37
Delayed Data
As of 3:53pm ET
 +1.43 / +3.98%
Today’s Change
29.60
Today|||52-Week Range
37.73
+5.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$34.1B

Company Description

CSL Ltd. is a biopharmaceutical company. It researches, develops, manufactures and markets vaccines and plasma protein biotherapies to treat and prevent human medical conditions. The company operates its business through two segments: CSL Behring and bioCSL. The CSL Behring segment provides plasma-derived and recombinant products, and operates plasma collection networks through CSL Plasma. The bioCSL segment manufactures, sells and distributes vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand; and also manufactures and markets in vitro diagnostic products through Immunohaematology. It has manufacturing operations in Germany, Switzerland and the United States. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

Contact Information

CSL Ltd.
45 Poplar Road
Parkville Victoria (vic) 3052
P:(139) 389-1911
Investor Relations:
(139) 389-2818

Employees

Shareholders

Other institutional0.41%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Paul Roger PerreaultChief Executive Officer, Executive Director & MD
Gordon NaylorChief Financial Officer
Andrew CuthbertsonChief Scientific Officer
Mark DehringDirector-Investor Relations
Sharon McHaleSenior Director-Public Affairs